Alumis Inc. closed $259M in an upsized Series C funding round led by venture capital investors.
Amount Raised
$259 Million
Round Type
Series C
Investors
Description
South San Francisco-based Alumis Inc. announced the closing of its upsized Series C funding round, securing $259 million from venture capital investors.
Quick answer
Alumis raised $259 Million in a Series C round, dated March 6, 2024. Investors: Venture Capital Investors. Alumis is based in Los Angeles, California, United States.
- How much did Alumis raise?
- Alumis raised $259 Million in a Series C round on March 6, 2024.
- Who invested in Alumis?
- Venture Capital Investors is named as investors in this round.
- What does Alumis do?
- A California-based biotech company specializing in developing oral therapies for immune dysfunction and autoimmune indications, with a focus on TYK2 inhibition.
- Where is Alumis based and how big is it?
- Alumis is based in Los Angeles, California, United States.
- Who are the decision-makers at Alumis?
- Fundz holds 1 contact at Alumis. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Alumis, and when
A new round usually means Alumis is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Alumis raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alumis, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alumis. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alumis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Alumis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.